GLPG0778

DRUG2 trials

Sponsors

Galapagos NV

Conditions

Healthy

Phase 1

First-in-Human Single Ascending and Multiple Dose of GLPG0778

CompletedNCT01278108

Galapagos NVHealthy

Start: 2010-12-31End: 2011-05-31Target: 40Updated: 2011-10-18

GLPG0778: Multiple Ascending Oral Doses, Pharmacokinetic, Safety, and Pharmacodynamic Study

CompletedNCT01336244

Galapagos NVHealthy

Start: 2011-04-30End: 2011-09-30Updated: 2011-10-18